HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chee-Yin Chai Selected Research

Adenoma (Adenomas)

9/2015Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
8/2007The expression of CD66a and possible roles in colorectal adenoma and adenocarcinoma.
2/2006Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
11/2005Computerized nuclear morphometry in thyroid follicular neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chee-Yin Chai Research Topics

Disease

101Neoplasms (Cancer)
01/2023 - 01/2002
33Carcinogenesis
07/2019 - 09/2004
20Carcinoma (Carcinomatosis)
12/2022 - 08/2003
15Inflammation (Inflammations)
11/2022 - 02/2007
14Neoplasm Metastasis (Metastasis)
01/2023 - 03/2004
11Rectal Neoplasms (Rectal Cancer)
11/2022 - 05/2012
10Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 05/2007
9Burns
12/2022 - 01/2015
9Hepatocellular Carcinoma (Hepatoma)
12/2018 - 10/2008
9Breast Neoplasms (Breast Cancer)
09/2018 - 05/2011
8Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 12/2013
8Pulmonary Hypertension
01/2021 - 03/2004
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 04/2007
6Vascular Remodeling
01/2021 - 11/2004
5Fibrosis (Cirrhosis)
01/2023 - 03/2005
5Neuralgia (Stump Neuralgia)
01/2023 - 01/2014
5Bowen's Disease (Disease, Bowen)
11/2018 - 09/2004
5Adenocarcinoma
05/2017 - 01/2006
5Hypoxia (Hypoxemia)
07/2016 - 08/2008
4Cholesteatoma
06/2023 - 10/2003
4Infections
01/2023 - 01/2007
4Left Ventricular Dysfunction
01/2020 - 06/2006
4Stomach Neoplasms (Stomach Cancer)
10/2017 - 08/2003
4Adenoma (Adenomas)
09/2015 - 11/2005
3Middle Ear Cholesteatoma
06/2023 - 10/2003
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
06/2022 - 01/2021
3Hyperglycemia
06/2022 - 05/2017
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2016
3Atrophy
01/2020 - 01/2015
3Hyperalgesia
04/2019 - 01/2014
3Skin Neoplasms (Skin Cancer)
11/2018 - 09/2004
3Aneuploidy (Aneuploid)
02/2018 - 09/2006
3Triple Negative Breast Neoplasms
01/2018 - 02/2016
3Brain Neoplasms (Brain Tumor)
04/2017 - 05/2012
3Body Weight (Weight, Body)
08/2016 - 01/2007
3Right Ventricular Hypertrophy
05/2015 - 06/2010
3Lung Neoplasms (Lung Cancer)
11/2014 - 07/2011
3Nasal Polyps (Nasal Polyp)
01/2013 - 08/2008
3Adenocarcinoma of Lung
05/2012 - 01/2006
3Verrucous Carcinoma
05/2010 - 06/2003

Drug/Important Bio-Agent (IBA)

48Proteins (Proteins, Gene)FDA Link
06/2023 - 01/2002
16ArsenicIBA
12/2022 - 09/2004
14Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2012
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2005
9Indicators and Reagents (Reagents)IBA
01/2022 - 09/2005
7salicylhydroxamic acid (SHAM)IBA
01/2020 - 03/2004
6arseniteIBA
12/2022 - 11/2007
6Phosphotransferases (Kinase)IBA
11/2022 - 09/2015
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 04/2007
6Messenger RNA (mRNA)IBA
06/2016 - 01/2002
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2013 - 11/2007
5CytokinesIBA
01/2021 - 08/2008
5Small Interfering RNA (siRNA)IBA
07/2019 - 01/2012
5Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2017 - 03/2004
5KMUP 1IBA
08/2016 - 05/2009
5STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2016 - 09/2005
4LipidsIBA
01/2023 - 05/2016
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2011
4Carrier Proteins (Binding Protein)IBA
12/2022 - 06/2016
4Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2014
4Cadherins (E-Cadherin)IBA
01/2020 - 01/2017
4Cyclin D1IBA
07/2019 - 04/2008
4Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2018 - 01/2017
4DNA (Deoxyribonucleic Acid)IBA
02/2018 - 05/2005
4rho-Associated KinasesIBA
01/2017 - 06/2010
4Matrix Metalloproteinases (MMPs)IBA
08/2016 - 01/2011
4Hormones (Hormone)IBA
01/2016 - 01/2012
4ParaffinIBA
08/2007 - 08/2003
3CalreticulinIBA
06/2023 - 05/2005
3Kazal Pancreatic Trypsin InhibitorIBA
11/2022 - 09/2015
3Serine (L-Serine)FDA Link
11/2022 - 04/2016
3TrypsinIBA
11/2022 - 09/2015
3IntegrinsIBA
12/2021 - 09/2013
3AntigensIBA
01/2021 - 08/2003
3CaspasesIBA
11/2020 - 01/2019
3Caspase 3 (Caspase-3)IBA
11/2020 - 07/2019
3Lysine (L-Lysine)FDA Link
01/2020 - 10/2017
3Beclin-1IBA
12/2019 - 12/2013
3Cisplatin (Platino)FDA LinkGeneric
10/2017 - 11/2014
3EnzymesIBA
01/2017 - 05/2009
3CateninsIBA
01/2017 - 01/2013
3Endothelin-1 (Endothelin 1)IBA
01/2017 - 03/2004
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2016 - 01/2012
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2016 - 09/2006
3ErbB Receptors (EGF Receptor)IBA
04/2016 - 10/2003
3AntioxidantsIBA
10/2013 - 05/2011
3Drinking WaterIBA
07/2013 - 09/2006
3Caveolin 1IBA
10/2012 - 07/2007
3phthalic acid (phthalate)IBA
08/2012 - 01/2012
3butylbenzyl phthalate (benzyl butyl phthalate)IBA
08/2012 - 01/2012
3Methotrexate (Mexate)FDA LinkGeneric
05/2010 - 06/2003
3AntibodiesIBA
03/2009 - 01/2006
3Telomerase (Telomerase Reverse Transcriptase)IBA
04/2008 - 01/2005
3Monoclonal AntibodiesIBA
08/2007 - 08/2003

Therapy/Procedure

20Therapeutics
01/2021 - 05/2005
12Chemoradiotherapy
11/2022 - 05/2012
10Radiotherapy
01/2023 - 09/2007
9Drug Therapy (Chemotherapy)
04/2017 - 06/2003
4Adjuvant Chemotherapy
11/2014 - 06/2005
3Transplantation
12/2017 - 01/2013